Page History
...
These biomarkers may be used to evaluate the pharmacokinetic of the tobacco product. Typical, when these biomarkers are measured serially after the specific tobacco product is used to determine well defined pharmacokinetic parameters ( e.g., AUC, TMX, T 1/2 ) the concentration level at the pre-specified timepoints would be represented in the PC/PK SDTM domains ( Pharmacokinetics Concentration and Parameters), otherwise these biomarkers would be represented in the LB domain.
| Example | ||||||
|---|---|---|---|---|---|---|
|
Overview
Content Tools